| GC10007-50mg |
|
1137608-69-5 |
LX1606 Hippurate (Telotristat etiprate)
|
0 |
C36H35ClF3N7O6 |
|
|
|
| GC10007-10mg |
|
1137608-69-5 |
LX1606 Hippurate (Telotristat etiprate)
|
0 |
C36H35ClF3N7O6 |
|
|
|
| GC10007-5mg |
|
1137608-69-5 |
LX1606 Hippurate (Telotristat etiprate)
|
0 |
C36H35ClF3N7O6 |
|
|
|
| GC10006-10mM (in 1mL DMSO) |
|
59804-37-4 |
|
0 |
C13H11N3O4S2 |
|
|
|
| GC10006-50mg |
|
59804-37-4 |
|
0 |
C13H11N3O4S2 |
|
|
|
| GC10005-10mM (in 1mL DMSO) |
|
1516895-53-6 |
|
0 |
C21H21N7 |
|
|
|
| GC10005-25mg |
|
1516895-53-6 |
|
0 |
C21H21N7 |
|
|
|
| GC10005-5mg |
|
1516895-53-6 |
|
0 |
C21H21N7 |
|
|
|
| GC10004-50mg |
|
77671-31-9 |
|
0 |
C12H12N2O2S |
|
|
|
| GC10004-10mg |
|
77671-31-9 |
|
0 |
C12H12N2O2S |
|
|
|
| GC10003-100mg |
|
314-19-2 |
(−)-Apomorphine (hydrochloride)
|
0 |
C17H17NO2.HCl |
|
|
|
| GC10003-10mM (in 1mL DMSO) |
|
314-19-2 |
(−)-Apomorphine (hydrochloride)
|
0 |
C17H17NO2.HCl |
|
|
|
| GC10003-50mg |
|
314-19-2 |
(−)-Apomorphine (hydrochloride)
|
0 |
C17H17NO2.HCl |
|
|
|
| GC10002-10mg |
|
479-13-0 |
|
0 |
C15H8O5 |
|
|
|
| GC10002-5mg |
|
479-13-0 |
|
0 |
C15H8O5 |
|
|
|
| GC10001-200mg |
|
82159-09-9 |
|
0 |
C15H13NO3S2 |
|
|
|
| GC10001-50mg |
|
82159-09-9 |
|
0 |
C15H13NO3S2 |
|
|
|
| GC10001-10mg |
|
82159-09-9 |
|
0 |
C15H13NO3S2 |
|
|
|
| GA24017-5mg |
|
153045-21-7 |
Human CMV pp65 (495-503) trifluoroacetate salt
|
0 |
C₄₂H₇₄N₁₀O₁₂S |
|
|
|
| GA24017-1mg |
|
153045-21-7 |
Human CMV pp65 (495-503) trifluoroacetate salt
|
0 |
C₄₂H₇₄N₁₀O₁₂S |
|
|
|
